Skip to main content

Gerald Cox, Kenneth LeClair, and Semiramis Trotto

Editas Medicine has expanded its senior management team by appointing Gerald Cox as chief medical officer, Kenneth LeClair as vice president of technical development and manufacturing, and Semiramis Trotto as vice president of human resources. Cox has held senior clinical development roles at Sanofi Genzyme (formerly Genzyme) for over 15 years. He most recently served as vice president of rare disease clinical development at Sanofi Genzyme. Cox also continues to serve in a part-time role as staff physician in genetics at Boston Children's Hospital. LeClair joins Editas from Novartis Pharmaceuticals, where he served as executive director of technical research and development of the cell and gene therapies unit. He has also worked as a postdoctoral research fellow at the MIT Center for Cancer Research and as an assistant professor of medicine at the Beth Israel Deaconess Medical Center at Harvard Medical School. Trotto comes to Editas from Baxalta, where she most recently served as the vice president of human resources in oncology. Before her time at Baxalta she spent over a decade at Bristol-Myers Squibb where she was responsible for human resources across a number of different business function in the US and internationally.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.